Studies

  1. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

  2. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

  3. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach

  4. Fungi and inflammatory bowel diseases: Alterations of composition and diversity

  5. On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease

  6. Isolation of *Mycobacterium avium* Subspecies *paratuberculosis* Reactive CD4 T Cells from Intestinal Biopsies of Crohn’s Disease Patients

  7. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn’s disease

  8. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn’s disease

  9. Dysbiosis of fecal microbiota in Crohn’s disease patients as revealed by a custom phylogenetic microarray

  10. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease